Actionable insights straight to your inbox

logo_equities.svg

Synageva Biopharma Corp. Files SEC Form S-8, Securities To Be Offered To Employees in Employee Benefit Plans (Jun. 26, 2014)

By a News Reporter-Staff News Editor at Biotech Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing

By a News Reporter-Staff News Editor at Biotech Week — According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Synageva Biopharma Corp. (Form S-8) was posted on June 26, 2014.
The SIC code for this company is 2836, Biological Products, (No Diagnostic Substances).
There were 4 documents filed with this form. The SEC file number is 0001193125-14-251115.
The contact information for this company is 33 HAYDEN AVE., LEXINGTON MA 02421, (781) 357-9900.
Our editors provided additional information about Form S-8: This form is used for the registration of securities to be offered to an issuer’s employees pursuant to certain plans.
A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.
For additional information on this SEC filing see: http://www.sec.gov/Archives/edgar/data/911326/0001193125-14-251115-index.html.
Keywords for this news article include: Pharmaceutical Companies, Drugs, Therapy, SEC Filing, Biopharmaceuticals, Biological Products, Synageva Biopharma Corp., (No Diagnostic Substances).
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

Many of us economy-watchers have been expecting recession, though with significant differences on odds and timing. Regardless, recent banking developments just made recession more likely and may have accelerated its onset.
Many people think of position size in terms of how many shares they own of a particular stock. But it’s much smarter to think of it in terms of what percentage of your total capital is in a particular stock.